Table 7.
The incremental predictive value of the METS-IR for MACE in the model 2 and model 3
| C-statistic (95%CI) | p-value | Continuous NRI (95%CI) | p-value | IDI (95%CI) | p-value | |
|---|---|---|---|---|---|---|
| Model2 without METR-IR | 0.692 (0.637–0.747) | < 0.001 | Ref | Ref | ||
| Model2 with METR-IR | 0.711 (0.677–0.745) | 0.266 (0.125–0.408) | < 0.001 | 0.020 (0.010–0.029) | < 0.001 | |
| Model3 without METR-IR | 0.702 (0.667–0.737) | < 0.001 | Ref | Ref | ||
| Model3 with METR-IR | 0.720 (0.686–0.754) | 0.305 (0.164–0.446) | < 0.001 | 0.021 (0.011–0.031) | < 0.001 |
METS-IR the metabolic score for insulin resistance, MACE major adverse cardiovascular events, NRI net reclassification improvement, IDI integrated discrimination improvement, Ref. reference
p values in bold are < 0.05